Skip to main content
. 2022 Feb 16;14(4):823. doi: 10.3390/nu14040823
IR Insulin resistance
T2DM Type 2 diabetes
HDL High density lipoprotein cholesterol
IGT Impaired glucose tolerance
GI Glycemic index
GL Glycemic load
NEFA Non-esterified free fatty acids
CVD Cardiovascular disease
NAFLD Non-alcoholic fatty liver disease
CNS Central nervous system
HGP Hepatic glucose production
GLP-1 Glucagon-like peptide 1
GIP Glucose-dependent insulinotropic polypeptide
HbA1c Glycated hemoglobin A1c
NGT Normal glucose tolerance
BP Blood pressure
RCT Randomized Controlled Clinical Trial
ADA American Diabetes Association
VLC Very low carbohydrate
IRS Insulin receptor substrate
GLUT Glucose transporter
HOMA-IR Homeostatic model assessment for insulin resistance
SCN Suprachiasmatic nucleus
VLCD Very low calorie diet
BMI Body mass index
Per Period
LDL Low density lipoprotein cholesterol
PCO Polycystic Ovary Syndrome
OGTT Oral glucose tolerance test
IF Intermittent fasting
ADF Alternate day fasting
TRF Time restricted feeding
IGF-1 Insulin-like growth factor-1
ROS Reactive Oxygen Species